How to Get Evkeeza (evinacumab-dgnb) Approved by Cigna in Texas: Timeline, Forms & Appeal Process

Quick Answer: Getting Evkeeza Approved by Cigna in Texas

Cigna requires prior authorization for Evkeeza (evinacumab-dgnb) to treat homozygous familial hypercholesterolemia (HoFH). Timeline: 7 days for standard review, 72 hours for urgent cases (effective 2026). First step: Gather HoFH diagnosis confirmation, prior therapy records, and recent LDL-C levels. Submit through Cigna's provider portal or specialty pharmacy like Accredo. If denied, Texas law provides internal appeals (180 days) and independent external review through Texas Department of Insurance.

Start today: Contact your prescriber to begin prior authorization paperwork and ensure all step therapy requirements are documented.


Table of Contents


What Affects Evkeeza Approval Timing

Several factors influence how quickly Cigna processes your Evkeeza (evinacumab-dgnb) prior authorization in Texas:

Benefit Type & Plan Structure

  • Medicare Advantage plans follow federal timelines (7 days standard, 72 hours expedited starting 2026)
  • Commercial employer plans may have varying timelines but increasingly align with federal standards
  • Specialty pharmacy coordination through Express Scripts Accredo can streamline the process

Complexity of Clinical Criteria Evkeeza has specific approval requirements including:

  • Confirmed HoFH diagnosis (genetic testing or clinical manifestations)
  • Age ≥5 years
  • Documentation of prior therapy trials (statins, PCSK9 inhibitors, ezetimibe)
  • Recent LDL-C levels demonstrating inadequate control

Documentation Completeness Complete submissions with all required elements typically receive faster approval than those requiring additional information requests.


Pre-Submission Preparation (0-2 Days)

Essential Documentation Checklist

Patient Information

  • Insurance card (front and back)
  • Member ID and group number
  • Patient weight and height (for dosing calculations)

Clinical Documentation

  • HoFH diagnosis confirmation through one of:
    • Genetic testing results showing LDL-receptor mutations
    • Clinical manifestations before age 10 (xanthomas, arcus cornea)
    • Family history with parent having untreated LDL-C ≥190 mg/dL
  • Most recent lipid panel showing LDL-C levels
  • Prior therapy documentation including:
    • High-intensity statin trial (unless contraindicated)
    • PCSK9 inhibitor trial for ≥8 weeks with LDL-C remaining ≥70 mg/dL
    • Ezetimibe trial (where appropriate)

Prescriber Requirements

  • Specialist involvement (cardiologist, lipidologist, or endocrinologist preferred)
  • Medical necessity letter detailing treatment rationale
  • Prescription with appropriate dosing (15 mg/kg IV every 4 weeks)
Tip: Organize all documents in a single folder before starting the submission process. Missing documentation is the #1 cause of approval delays.

Submission to Initial Review (1-7 Days)

How to Submit Your Prior Authorization

Electronic Submission (Fastest)

  • Cigna provider portal for direct submission
  • CoverMyMeds integration for streamlined processing
  • Express Scripts specialty pharmacy coordination

Required Submission Elements

  1. Completed prior authorization form
  2. Prescriber attestation of medical necessity
  3. Clinical documentation package
  4. Recent laboratory results
  5. Prior therapy failure documentation

What Reviewers Check First

Cigna's utilization management team initially verifies:

  • Patient meets age requirement (≥5 years)
  • HoFH diagnosis is properly documented
  • Prior therapy requirements are satisfied
  • Dosing aligns with FDA labeling

Texas-Specific Timeline Requirements Under new federal regulations effective 2026, Cigna must respond within:

  • Standard requests: 7 calendar days
  • Expedited requests: 72 hours

Additional Information Requests (1-7 Days)

If Cigna requests additional information, respond quickly to avoid delays:

Common Information Requests

  • Updated LDL-C levels if labs are >6 months old
  • Detailed prior therapy timeline with specific medications, doses, and duration
  • Specialist consultation notes
  • Genetic testing results (if clinical diagnosis was used initially)

How to Respond Efficiently

  • Submit via the same portal used for initial submission
  • Include the original prior authorization reference number
  • Provide a cover letter summarizing the additional information
Note: You typically have 14 days to respond to information requests before the case is closed and requires resubmission.

Decision Window & Reading Approval Letters

Typical Outcomes

Approval

  • Coverage approved for initial 6-12 month period
  • Specialty pharmacy coordination details provided
  • Renewal requirements outlined

Partial Approval

  • Coverage approved with modifications (quantity limits, site of care restrictions)
  • May require additional documentation for full approval

Denial

  • Specific denial reason provided
  • Appeal rights and deadlines included
  • Instructions for additional information submission

Understanding Your Approval Letter

Key elements to verify in approval notifications:

  • Approved duration of coverage
  • Quantity limits or dosing restrictions
  • Required specialty pharmacy (typically Accredo)
  • Renewal timeline and requirements

If Denied: Texas Appeal Process

Texas provides robust appeal rights for Cigna denials, especially for specialty medications like Evkeeza.

Internal Appeal Process

Step 1: File Internal Appeal

  • Deadline: 180 calendar days from denial date
  • Submit to: Cigna appeals department
  • Required documents: Original denial letter, medical records, prescriber letter

Step 2: Expedited Internal Appeal (if urgent)

  • Available when delay could jeopardize health
  • Must be resolved within 30 days or sooner
  • Can be filed simultaneously with standard appeal

External Review Through Texas IRO

If Cigna upholds the denial, Texas law provides independent external review:

Texas Independent Review Organization Process

  • Available for: Medical necessity denials, experimental/investigational determinations
  • Timeline: Request within 4 months of final internal denial
  • Cost: Paid by insurer
  • Decision timeframe: 20 days standard, 5 days expedited
  • Binding: IRO decision is final and binding on Cigna

IRO Success Rates External reviews in Texas overturn insurer denials approximately 40-50% of the time for well-documented specialty drug cases, particularly for rare disease medications like Evkeeza.

How to Request IRO Review

  • Contact Texas Department of Insurance at 1-800-252-3439
  • Complete IRO request form (provided with final denial)
  • Submit all supporting medical documentation

Renewal Cycles & Ongoing Coverage

Initial Approval Period

  • Duration: Typically 6-12 months for first approval
  • Requirements: Demonstration of clinical response (LDL-C reduction)

Renewal Process

  • Timeline: Begin renewal 30-60 days before expiration
  • Documentation needed:
    • Updated clinical response data
    • Continued medical necessity
    • Any changes in clinical status
    • Prescriber attestation of ongoing benefit

What Speeds Up Renewals

  • Consistent specialty pharmacy relationship
  • Well-documented clinical response
  • Proactive submission before expiration

Timeline Visual & Milestones

Phase Timeline Key Activities Success Factors
Preparation 0-2 days Gather documentation, verify insurance Complete clinical records
Submission Day 1 Submit PA through portal/pharmacy Electronic submission preferred
Initial Review 1-7 days Cigna reviews clinical criteria Meet all step therapy requirements
Additional Info 1-7 days Respond to requests if needed Quick response within 14 days
Decision 7-14 days total Approval/denial issued Strong medical necessity case
Appeal (if needed) 180 days Internal appeal process Comprehensive documentation
External Review 4 months Texas IRO review available Independent clinical assessment

Time-Saving Tips for Faster Approval

Portal Usage Best Practices

  • Use electronic submission whenever possible
  • Upload all documents in a single session
  • Include cover letter summarizing clinical rationale

Bundled Evidence Strategy

  • Submit comprehensive documentation package initially
  • Include both required and supporting materials
  • Provide clear medical necessity narrative

Direct Specialty Routing

  • Coordinate with Accredo or approved specialty pharmacy early
  • Leverage pharmacy's prior authorization support services
  • Ensure prescriber is registered with specialty pharmacy network

From Our Advocates: We've seen cases where patients who worked directly with their specialty pharmacy's prior authorization team from the beginning experienced approval times 3-5 days faster than those who went through traditional channels. The key was having the pharmacy coordinate directly with Cigna while the prescriber focused on clinical documentation.


Common Denial Reasons & Solutions

Denial Reason How to Address Required Documentation
Insufficient HoFH documentation Provide genetic testing or detailed clinical criteria Genetic report or clinical manifestation records
Missing prior therapy trials Document statin, PCSK9 inhibitor, ezetimibe attempts Pharmacy records, prescriber notes, failure reasons
Inadequate LDL-C levels Submit recent lipid panels showing persistent elevation Labs within 6 months showing LDL-C ≥70 mg/dL
Age requirement not met Verify patient is ≥5 years old Birth certificate or medical records
Quantity/dosing concerns Confirm 15 mg/kg every 4 weeks dosing Weight-based calculation, FDA labeling reference

Frequently Asked Questions

How long does Cigna prior authorization take for Evkeeza in Texas? Standard prior authorization takes up to 7 days, with expedited review available in 72 hours for urgent cases (2026 timeline). Most complete submissions receive decisions within 3-5 business days.

What if Evkeeza is not on Cigna's formulary? Evkeeza is typically covered as a specialty medication requiring prior authorization. If listed as non-formulary, request a formulary exception with medical necessity documentation.

Can I request an expedited appeal in Texas? Yes, expedited appeals are available when delays could jeopardize your health. Both internal appeals and external IRO reviews have expedited options.

Does step therapy apply if I've tried these medications in another state? Yes, prior therapy documentation from any location is acceptable as long as you have medical records showing the trials and outcomes.

What specialty pharmacy should I use for Evkeeza? Cigna typically requires Accredo (Express Scripts) or other contracted specialty pharmacies. Verify with your plan's specialty pharmacy network.

How much does Evkeeza cost with Cigna coverage? Costs vary by plan, but specialty tier medications typically have higher copays. Manufacturer copay assistance and patient assistance programs may be available.

What happens if the external review is denied? IRO decisions are binding, but you may have options through manufacturer patient assistance programs or other coverage sources.

Can I appeal while continuing current treatment? Appeal rights don't guarantee continued coverage during the process unless specifically approved. Discuss bridge therapy options with your prescriber.


Getting Additional Support

Counterforce Health specializes in turning insurance denials into successful appeals for complex medications like Evkeeza. Their platform analyzes denial letters, identifies specific coverage criteria, and drafts evidence-backed appeals that align with Cigna's own policies. By pulling the right clinical citations and weaving them into targeted rebuttals, Counterforce Health helps patients and clinicians navigate the prior authorization process more effectively, reducing the back-and-forth that often delays access to critical medications.

For patients facing repeated denials or complex coverage situations, working with specialized advocacy services can significantly improve approval rates and reduce the time to access treatment.


Sources & Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions vary by individual plan and clinical circumstances. Always consult with your healthcare provider and insurance plan for specific guidance regarding your situation. For assistance with insurance appeals and coverage issues in Texas, contact the Texas Department of Insurance at 1-800-252-3439.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.